Copyright © GeneGuide 2013-2017

GeneGuide - About

GeneGuide is a Swiss company dedicated to the identification of novel drug targets and compounds for the treatment of neuropsychiatric disorders. We achieve this goal by combining our proprietary Genome-Based Drug Discovery technology with large-scale human behavioral, genetic and neuroimaging data. Promising drug candidates are tested in proof-of-concept (PoC) clinical trials.

Scientific rationale

Failed drug discovery in psychiatry: time for human genome-guided solutions. Andreas Papassotiropoulos & Dominique J.-F. de Quervain Trends Cogn Sci. 2015   -> paper.pdf

Finding new treatments

through human genomics